Our Pricing

Omeprazole vs Lansoprazole UK Comparison

Published on: June 03, 2026

When choosing between omeprazole vs lansoprazole UK comparison options, understanding the clinical differences helps you make an informed decision. Both proton pump inhibitors (PPIs) effectively reduce stomach acid production, but they differ in onset time, duration of action, and individual response rates. At Cured Pharmacy, our UK-registered clinical team can assess which PPI suits your specific symptoms through a free online consultation.

How Omeprazole and Lansoprazole Work

Both omeprazole and lansoprazole belong to the proton pump inhibitor (PPI) class, working by irreversibly blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells [1]. This mechanism reduces gastric acid secretion by up to 90%, providing relief from conditions like gastro-oesophageal reflux disease (GORD), peptic ulcers, and dyspepsia.

The key difference lies in their chemical structure and pharmacokinetics. Lansoprazole typically achieves peak plasma concentration faster than omeprazole — usually within 1.5 to 2 hours compared to omeprazole's 2 to 4 hours [2]. This faster onset may provide quicker symptom relief for some patients, though both medications require several days of consecutive dosing to reach maximum acid suppression.

Clinical studies show both PPIs achieve similar acid suppression over 24 hours when taken at equivalent doses, with lansoprazole 30mg broadly comparable to omeprazole 20mg in efficacy [1][2]. Individual response varies based on genetic factors affecting drug metabolism, particularly CYP2C19 enzyme activity.

Omeprazole vs Lansoprazole: Efficacy and Clinical Evidence

In head-to-head trials comparing omeprazole 20mg with lansoprazole 30mg for GORD treatment, healing rates at 8 weeks were statistically similar — approximately 80-85% for both medications [3]. A systematic review of PPI efficacy found no clinically significant difference in symptom relief or oesophagitis healing between the two drugs when used at standard doses.

Lansoprazole may offer a slight advantage in speed of symptom relief during the first few days of treatment due to its faster activation and absorption profile [2]. However, by day 5-7 of continuous therapy, both medications provide equivalent acid control and symptom management for most patients.

For maintenance therapy in preventing GORD recurrence, both omeprazole and lansoprazole demonstrate similar long-term efficacy, with remission rates exceeding 70% at 12 months when taken daily [3]. Your response to either medication may depend on individual factors including body weight, genetic polymorphisms in drug-metabolising enzymes, and concurrent medications.

Which PPI Works Faster?

Lansoprazole generally achieves therapeutic acid suppression slightly faster than omeprazole, with some patients reporting symptom improvement within 24-48 hours compared to 2-3 days for omeprazole [2]. This difference becomes negligible after the first week of treatment, as both medications reach steady-state acid suppression with similar clinical outcomes.

Side Effects: Omeprazole vs Lansoprazole

The side effect profiles of omeprazole and lansoprazole are remarkably similar, as both medications share the same mechanism of action [4]. Common side effects occurring in 1-10% of patients include headache, nausea, diarrhoea, constipation, abdominal pain, and flatulence. These effects are typically mild and resolve without discontinuing treatment.

Long-term PPI use (beyond 12 months) carries potential risks regardless of which medication you take, including increased risk of bone fractures, vitamin B12 deficiency, hypomagnesaemia, and Clostridium difficile infection [4]. The MHRA recommends using the lowest effective dose for the shortest duration necessary to control symptoms.

Some patients report better tolerability with one PPI over another, though this appears to be individual rather than a consistent pattern. If you experience side effects with omeprazole, switching to lansoprazole may be worth trying under prescriber guidance, and vice versa.

Drug Interactions to Consider

Both omeprazole and lansoprazole can interact with medications metabolised by CYP2C19 and CYP3A4 enzymes, including clopidogrel, warfarin, methotrexate, and certain antifungals [4]. Omeprazole tends to have slightly more pronounced interactions with clopidogrel, which is why lansoprazole is sometimes preferred in patients requiring dual antiplatelet therapy. Always inform your prescriber of all medications you're taking during your clinical assessment.

Dosing and Administration Differences

Standard omeprazole dosing for GORD is 20mg once daily, taken 30-60 minutes before breakfast, though 10mg may suffice for mild symptoms or maintenance therapy [1]. Lansoprazole is typically prescribed at 30mg once daily for active GORD, with 15mg used for maintenance or milder cases.

Both medications should be swallowed whole without crushing or chewing, as they contain enteric-coated granules designed to survive stomach acid and dissolve in the small intestine. Lansoprazole capsules can be opened and the granules mixed with soft food or dispersed in water for patients with swallowing difficulties, whereas standard omeprazole capsules should not be opened.

At Cured Pharmacy, we stock omeprazole capsules from £9.99 for both 10mg and 20mg strengths, and lansoprazole capsules from £9.99 in 15mg and 30mg doses. Timing consistency matters more than which PPI you choose — taking your medication at the same time each morning optimises acid suppression throughout the day.

Cost Comparison: Omeprazole vs Lansoprazole UK

Omeprazole is generally the more affordable option in the UK market, partly because it's been available as a generic medication for longer and has broader manufacturing competition. At Cured Pharmacy, omeprazole capsules start from £9.99, making it one of the most cost-effective PPI options available online.

Lansoprazole capsules are priced from £9.99 at Cured Pharmacy, reflecting competitive UK pricing for this widely prescribed PPI. Both medications represent excellent value compared to branded alternatives, while maintaining the same active pharmaceutical ingredients and therapeutic effects.

If cost is a primary concern and you have no specific clinical reason to prefer one PPI over the other, omeprazole offers the most economical choice. However, the price difference is modest, and clinical suitability should take precedence over cost when your prescriber makes their recommendation during your free online consultation.

Alternative PPI Options

Beyond omeprazole and lansoprazole, Cured Pharmacy stocks other PPIs including esomeprazole (from £9.99), pantoprazole (from £9.99), and branded options like Losec and Nexium. Esomeprazole is the S-isomer of omeprazole and may provide slightly enhanced acid suppression in some patients, whilst pantoprazole offers an alternative for those who don't respond optimally to first-line PPIs. Your UK prescriber will recommend the most appropriate option based on your medical history and symptom pattern.

Which PPI Should You Choose?

For most patients, either omeprazole or lansoprazole will effectively manage acid reflux symptoms when taken correctly [3]. Lansoprazole may be preferable if you need faster initial symptom relief or are taking clopidogrel, whilst omeprazole offers excellent efficacy at a lower cost point.

Clinical factors that might influence your prescriber's recommendation include your specific diagnosis (GORD, peptic ulcer, dyspepsia), symptom severity, previous PPI response, concurrent medications, and any history of side effects. Some patients are genetically poor metabolisers of omeprazole and respond better to lansoprazole, though this is relatively uncommon.

At Cured Pharmacy, our UK-registered clinical team conducts a comprehensive online assessment to determine which PPI suits your individual needs. The consultation takes under 3 minutes, and if a prescription is appropriate, your medication is dispensed by our GPhC-registered pharmacy and delivered discreetly to your door. All prescription PPIs require clinical assessment by a UK prescriber before dispensing, ensuring safe and appropriate treatment selection.

Scientific References

1. Stedman, C. A., & Barclay, M. L. (2000). Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963–978. https://doi.org/10.1046/j.1365-2036.2000.00788.x [accessed 13 August 2026]
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms. Clinical Pharmacology & Therapeutics, 85(6), 607–610. https://doi.org/10.1038/clpt.2009.27 [accessed 13 August 2026]
3. Gisbert, J. P., & Khorrami, S. (2009). Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Alimentary Pharmacology & Therapeutics, 30(7), 677–692. https://doi.org/10.1111/j.1365-2036.2009.04089.x [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2012). Proton pump inhibitors in long-term use: Reports of hypomagnesaemia. Drug Safety Update, 5(10), A1. https://www.gov.uk/drug-safety-update/proton-pump-inhibitors-in-long-term-use-reports-of-hypomagnesaemia [accessed 13 August 2026]
5. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.